SOURCE: Anti Aging Medical Group Corp.

January 23, 2007 08:30 ET

Anti Aging Medical Group Corp. Reports Corporate Milestones

TORONTO -- (MARKET WIRE) -- January 23, 2007 -- Anti Aging Medical Group Corp. (PINKSHEETS: AAGM), a specialty pharmaceutical company focused on developing, acquiring and commercializing innovative and scientifically proven products that offer both health maintenance and appearance enhancing benefits, announces that the company wishes to provide a corporate update.

The Company unveiled a new growth strategy last November to position itself for long term growth. One of the focused areas mentioned is a collaboration on anti aging therapeutics development. The Company is pleased to report that the collaboration is making good progress as pre-clinical study has been initiated for this project. The crucial in vivo anesthetic experiments are being conducted to confirm the drug candidate's neuro-protection activity. The Company believes that the market potential for this drug candidate exceeds US$2 billion.

The Company has conducted meetings with consumer health product distributors and are expecting proposals from them. The Company is confident that a deal will emerge and start to bring revenue to the company in the near-term.

About Anti Aging Medical Group Corp.

We are a specialty pharmaceutical company focused on developing, acquiring and commercializing innovative and scientifically proven products that offer both health maintenance and appearance enhancing benefits to all of us. For more information about us please visit our website at www.aamgcorp.com.

FORWARD-LOOKING STATEMENTS:

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.

Contact Information